Needham cuts Acadia Pharmaceuticals stock price target on trial results - Investing.com India
Source: Investing.com India ·
Needham cuts Acadia Pharmaceuticals stock price target on trial results Investing.com India
BestAIBroker analysis
- Finance-aware sentiment: negative (-0.40 on a -1 to +1 scale).
- Event classification: EARNINGS.
- Market importance score: 45/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
- Symbols referenced: ACAD.